Skip to main content
Top
Published in: Current Hypertension Reports 4/2013

01-08-2013 | Hypertension and the Heart (PW de Leeuw and AH Gradman, Section Editors)

Current Concepts in Orthostatic Hypotension Management

Authors: Amy C. Arnold, Cyndya Shibao

Published in: Current Hypertension Reports | Issue 4/2013

Login to get access

Abstract

Orthostatic hypotension is a condition commonly affecting the elderly and is often accompanied by disabling presyncopal symptoms, syncope and impaired quality of life. The pathophysiology of orthostatic hypotension is linked to abnormal blood pressure regulatory mechanisms and autonomic insufficiency. As part of its diagnostic evaluation, a comprehensive history and medical examination focused on detecting symptoms and physical findings of autonomic neuropathy should be performed. In individuals with substantial falls in blood pressure upon standing, autonomic function tests are recommended to detect impairment of autonomic reflexes. Treatment should always follow a stepwise approach with initial use of nonpharmacologic interventions including avoidance of hypotensive medications, high-salt diet and physical counter maneuvers. If these measures are not sufficient, medications such as fludrocortisone and midodrine can be added. The goals of treatment are to improve symptoms and to make the patient as ambulatory as possible instead of targeting arbitrary blood pressure values.
Literature
1.
go back to reference Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. J Clin Pharmacol. 1994;34:375–86.PubMedCrossRef Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. J Clin Pharmacol. 1994;34:375–86.PubMedCrossRef
2.
go back to reference Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72.PubMedCrossRef Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72.PubMedCrossRef
3.
go back to reference Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120:841–7.PubMedCrossRef Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120:841–7.PubMedCrossRef
4.
go back to reference Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens. 2011;24:135–44.PubMedCrossRef Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens. 2011;24:135–44.PubMedCrossRef
5.
go back to reference Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98:2290–5.PubMedCrossRef Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98:2290–5.PubMedCrossRef
6.
go back to reference Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006;114:630–6.PubMedCrossRef Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006;114:630–6.PubMedCrossRef
7.
go back to reference • Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31:85–91. This prospective study provides new information on the prevalence and determinants of OH in a middle aged community based population. Furthermore, individuals with OH had an increased risk for all-cause mortality and coronary events, which more strongly correlated to the decline in diastolic blood pressure with standing. PubMedCrossRef • Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31:85–91. This prospective study provides new information on the prevalence and determinants of OH in a middle aged community based population. Furthermore, individuals with OH had an increased risk for all-cause mortality and coronary events, which more strongly correlated to the decline in diastolic blood pressure with standing. PubMedCrossRef
8.
go back to reference Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000;31:2307–13.PubMedCrossRef Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000;31:2307–13.PubMedCrossRef
9.
go back to reference •• Franceschini N, Rose KM, Astor BC, et al. Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension. 2010;56:1054–9. This is the first report to show an association between OH at baseline and the risk for chronic kidney disease in middle aged community dwellers, particularly in blacks. These studies add to the list of adverse health outcomes associated with this condition. PubMedCrossRef •• Franceschini N, Rose KM, Astor BC, et al. Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension. 2010;56:1054–9. This is the first report to show an association between OH at baseline and the risk for chronic kidney disease in middle aged community dwellers, particularly in blacks. These studies add to the list of adverse health outcomes associated with this condition. PubMedCrossRef
10.
go back to reference Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19:508–19.PubMedCrossRef Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19:508–19.PubMedCrossRef
11.
go back to reference Shibao C, Grijalva CG, Raj SR, et al. Orthostatic hypotension-related hospitalizations in the United States. Am J Med. 2007;120:975–80.PubMedCrossRef Shibao C, Grijalva CG, Raj SR, et al. Orthostatic hypotension-related hospitalizations in the United States. Am J Med. 2007;120:975–80.PubMedCrossRef
12.
go back to reference Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17:625–8.PubMedCrossRef Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17:625–8.PubMedCrossRef
13.
go back to reference Bonuccelli U, Lucetti C, Del Dotto P, et al. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol. 2003;60:1400–4.PubMedCrossRef Bonuccelli U, Lucetti C, Del Dotto P, et al. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol. 2003;60:1400–4.PubMedCrossRef
14.
go back to reference Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63:584–9.PubMedCrossRef Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63:584–9.PubMedCrossRef
15.
go back to reference Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:1470–1.PubMedCrossRef Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:1470–1.PubMedCrossRef
16.
go back to reference Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27:2942–7.PubMedCrossRef Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27:2942–7.PubMedCrossRef
17.
go back to reference Ooi WL, Barrett S, Hossain M, et al. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA. 1997;277:1299–304.PubMedCrossRef Ooi WL, Barrett S, Hossain M, et al. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA. 1997;277:1299–304.PubMedCrossRef
18.
go back to reference Weiss A, Grossman E, Beloosesky Y, Grinblat J. Orthostatic hypotension in acute geriatric ward: is it a consistent finding? Arch Intern Med. 2002;162:2369–74.PubMedCrossRef Weiss A, Grossman E, Beloosesky Y, Grinblat J. Orthostatic hypotension in acute geriatric ward: is it a consistent finding? Arch Intern Med. 2002;162:2369–74.PubMedCrossRef
19.
go back to reference Jonsson PV, Lipsitz LA, Kelley M, Koestner J. Hypotensive responses to common daily activities in institutionalized elderly. A potential risk for recurrent falls. Arch Intern Med. 1990;150:1518–24.PubMedCrossRef Jonsson PV, Lipsitz LA, Kelley M, Koestner J. Hypotensive responses to common daily activities in institutionalized elderly. A potential risk for recurrent falls. Arch Intern Med. 1990;150:1518–24.PubMedCrossRef
20.
21.
go back to reference Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005;30:173–8.PubMedCrossRef Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005;30:173–8.PubMedCrossRef
22.
go back to reference Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study. Age Ageing. 2010;39:51–6.PubMedCrossRef Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study. Age Ageing. 2010;39:51–6.PubMedCrossRef
23.
go back to reference Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971;29:424–31.PubMedCrossRef Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971;29:424–31.PubMedCrossRef
24.
go back to reference Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension. 1998;32:298–304.PubMedCrossRef Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension. 1998;32:298–304.PubMedCrossRef
25.
go back to reference Parikh SM, Diedrich A, Biaggioni I, Robertson D. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci. 2002;200:1–10.PubMedCrossRef Parikh SM, Diedrich A, Biaggioni I, Robertson D. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci. 2002;200:1–10.PubMedCrossRef
26.
go back to reference Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology. 2001;56:980–1.PubMedCrossRef Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology. 2001;56:980–1.PubMedCrossRef
27.
go back to reference Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 1999;519(Pt 1):1–10.PubMedCrossRef Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 1999;519(Pt 1):1–10.PubMedCrossRef
28.
go back to reference Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci. 2009;146:3–7.PubMedCrossRef Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci. 2009;146:3–7.PubMedCrossRef
29.
go back to reference •• Li H, Kem DC, Reim S, et al. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012;59:402–8. These studies identified agonistic autoantibodies to β2-adrenergic and M3-muscarinic receptors in patients with symptomatic OH. There was a significant increase in IgG-induced activation of these receptors in patients compared to controls. Furthermore, the application of autoantibodies isolated from OH patients resulted in dose-dependent vasodilation in in vitro rat arteriole assays. These findings suggest a new potential mechanism that may contribute to OH in some patients. PubMedCrossRef •• Li H, Kem DC, Reim S, et al. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012;59:402–8. These studies identified agonistic autoantibodies to β2-adrenergic and M3-muscarinic receptors in patients with symptomatic OH. There was a significant increase in IgG-induced activation of these receptors in patients compared to controls. Furthermore, the application of autoantibodies isolated from OH patients resulted in dose-dependent vasodilation in in vitro rat arteriole assays. These findings suggest a new potential mechanism that may contribute to OH in some patients. PubMedCrossRef
30.
go back to reference Yu X, Stavrakis S, Hill MA, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens. 2012;6:40–7.PubMedCrossRef Yu X, Stavrakis S, Hill MA, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens. 2012;6:40–7.PubMedCrossRef
31.
go back to reference Tabara Y, Kohara K, Miki T. Polymorphisms of genes encoding components of the sympathetic nervous system but not the renin-angiotensin system as risk factors for orthostatic hypotension. J Hypertens. 2002;20:651–6.PubMedCrossRef Tabara Y, Kohara K, Miki T. Polymorphisms of genes encoding components of the sympathetic nervous system but not the renin-angiotensin system as risk factors for orthostatic hypotension. J Hypertens. 2002;20:651–6.PubMedCrossRef
32.
go back to reference Pankow JS, Dunn DM, Hunt SC, et al. Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens. 2005;18:672–8.PubMedCrossRef Pankow JS, Dunn DM, Hunt SC, et al. Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens. 2005;18:672–8.PubMedCrossRef
33.
go back to reference Luo F, Wang Y, Wang X, et al. A functional variant of NEDD4L is associated with hypertension, antihypertensive response, and orthostatic hypotension. Hypertension. 2009;54:796–801.PubMedCrossRef Luo F, Wang Y, Wang X, et al. A functional variant of NEDD4L is associated with hypertension, antihypertensive response, and orthostatic hypotension. Hypertension. 2009;54:796–801.PubMedCrossRef
34.
go back to reference Fedorowski A, Franceschini N, Brody J, et al. Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium. Eur Heart J. 2012;33:2331–41.PubMedCrossRef Fedorowski A, Franceschini N, Brody J, et al. Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium. Eur Heart J. 2012;33:2331–41.PubMedCrossRef
35.
go back to reference Stemberger S, Scholz SW, Singleton AB, Wenning GK. Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging. 2011;32:1924–14.PubMedCrossRef Stemberger S, Scholz SW, Singleton AB, Wenning GK. Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging. 2011;32:1924–14.PubMedCrossRef
36.
go back to reference Shibao C, Garland EM, Gamboa A, et al. PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin Auton Res. 2008;18:13–9.PubMedCrossRef Shibao C, Garland EM, Gamboa A, et al. PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin Auton Res. 2008;18:13–9.PubMedCrossRef
37.
go back to reference Biaggioni I, Hollister AS, Robertson D. Dopamine in dopamine-β-hydroxylase deficiency. N Engl J Med. 1987;314:1415–6. Biaggioni I, Hollister AS, Robertson D. Dopamine in dopamine-β-hydroxylase deficiency. N Engl J Med. 1987;314:1415–6.
38.
go back to reference Carlson JE. Assessment of orthostatic blood pressure: measurement technique and clinical applications. South Med J. 1999;92:167–73.PubMedCrossRef Carlson JE. Assessment of orthostatic blood pressure: measurement technique and clinical applications. South Med J. 1999;92:167–73.PubMedCrossRef
39.
go back to reference Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology. 2006;67:28–32.PubMedCrossRef Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology. 2006;67:28–32.PubMedCrossRef
40.
go back to reference Lahrmann H, Cortelli P, Hilz M, et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006;13:930–6.PubMedCrossRef Lahrmann H, Cortelli P, Hilz M, et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006;13:930–6.PubMedCrossRef
42.
go back to reference Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41:587–94.PubMedCrossRef Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41:587–94.PubMedCrossRef
43.
go back to reference Krediet CT, van Lieshout JJ, Bogert LW, et al. Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study. Am J Physiol Heart Circ Physiol. 2006;291:H1768–72.PubMedCrossRef Krediet CT, van Lieshout JJ, Bogert LW, et al. Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study. Am J Physiol Heart Circ Physiol. 2006;291:H1768–72.PubMedCrossRef
44.
go back to reference Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res. 1993;3:57–65.PubMedCrossRef Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res. 1993;3:57–65.PubMedCrossRef
45.
go back to reference Smit AA, Wieling W, Fujimura J, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004;14:167–75.PubMedCrossRef Smit AA, Wieling W, Fujimura J, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004;14:167–75.PubMedCrossRef
46.
go back to reference Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006;48:1425–32.PubMedCrossRef Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006;48:1425–32.PubMedCrossRef
47.
go back to reference Jordan J, Shannon JR, Grogan E, et al. A potent pressor response elicited by drinking water. Lancet. 1999;353:723.PubMedCrossRef Jordan J, Shannon JR, Grogan E, et al. A potent pressor response elicited by drinking water. Lancet. 1999;353:723.PubMedCrossRef
48.
go back to reference Jordan J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep. 2005;7:17–20.PubMedCrossRef Jordan J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep. 2005;7:17–20.PubMedCrossRef
49.
go back to reference Ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232:139–45.PubMedCrossRef Ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232:139–45.PubMedCrossRef
50.
go back to reference van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35–42.PubMedCrossRef van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35–42.PubMedCrossRef
51.
go back to reference Shibao C, Lipsitz LA, Biaggioni I. ASH Position Paper: Evaluation and Treatment of Orthostatic Hypotension. J Clin Hypertens. 2013;15:147–53.CrossRef Shibao C, Lipsitz LA, Biaggioni I. ASH Position Paper: Evaluation and Treatment of Orthostatic Hypotension. J Clin Hypertens. 2013;15:147–53.CrossRef
52.
go back to reference Shibao C, Raj SR, Gamboa A, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50:47–53.PubMedCrossRef Shibao C, Raj SR, Gamboa A, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50:47–53.PubMedCrossRef
53.
go back to reference Onrot J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurology. 1987;37:215–20.PubMedCrossRef Onrot J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurology. 1987;37:215–20.PubMedCrossRef
54.
go back to reference Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847–51.PubMedCrossRef Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847–51.PubMedCrossRef
55.
go back to reference Jordan J, Shannon JR, Biaggioni I, et al. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105:116–24.PubMedCrossRef Jordan J, Shannon JR, Biaggioni I, et al. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105:116–24.PubMedCrossRef
56.
go back to reference Singer W, Opfer-Gehrking TL, McPhee BR, et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294–8.PubMedCrossRef Singer W, Opfer-Gehrking TL, McPhee BR, et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294–8.PubMedCrossRef
57.
go back to reference Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab. 1998;83:339–43.PubMedCrossRef Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab. 1998;83:339–43.PubMedCrossRef
58.
go back to reference Jordan J, Shannon JR, Diedrich A, et al. Water potentiates the pressor effect of ephedra alkaloids. Circulation. 2004;109:1823–5.PubMedCrossRef Jordan J, Shannon JR, Diedrich A, et al. Water potentiates the pressor effect of ephedra alkaloids. Circulation. 2004;109:1823–5.PubMedCrossRef
59.
go back to reference Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650–6.PubMedCrossRef Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650–6.PubMedCrossRef
60.
go back to reference Lipsitz LA, Nyquist Jr RP, Wei JY, Rowe JW. Postprandial reduction in blood pressure in the elderly. N Engl J Med. 1983;309:81–3.PubMedCrossRef Lipsitz LA, Nyquist Jr RP, Wei JY, Rowe JW. Postprandial reduction in blood pressure in the elderly. N Engl J Med. 1983;309:81–3.PubMedCrossRef
61.
go back to reference Mathias CJ. Postprandial hypotension. Pathophysiological mechanisms and clinical implications in different disorders. Hypertension. 1991;18:694–704.PubMedCrossRef Mathias CJ. Postprandial hypotension. Pathophysiological mechanisms and clinical implications in different disorders. Hypertension. 1991;18:694–704.PubMedCrossRef
62.
go back to reference Vloet LC, Pel-Little RE, Jansen PA, Jansen RW. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to Dutch hospitals. J Gerontol A Biol Sci Med Sci. 2005;60:1271–7.PubMedCrossRef Vloet LC, Pel-Little RE, Jansen PA, Jansen RW. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to Dutch hospitals. J Gerontol A Biol Sci Med Sci. 2005;60:1271–7.PubMedCrossRef
63.
go back to reference Robertson D, Wade D, Robertson RM. Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunction states. Am J Cardiol. 1981;48:1048–52.PubMedCrossRef Robertson D, Wade D, Robertson RM. Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunction states. Am J Cardiol. 1981;48:1048–52.PubMedCrossRef
64.
go back to reference Onrot J, Goldberg MR, Biaggioni I, et al. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med. 1985;313:549–54.PubMedCrossRef Onrot J, Goldberg MR, Biaggioni I, et al. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med. 1985;313:549–54.PubMedCrossRef
65.
go back to reference Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54–61.PubMedCrossRef Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54–61.PubMedCrossRef
66.
go back to reference Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383–9.PubMedCrossRef Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383–9.PubMedCrossRef
67.
go back to reference • Valbusa F, Labat C, Salvi P, et al. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30:53–60. This study examined the prevalance of OH in elderly persons living in nursing homes, and showed a positive association of this condition with arterial stiffness and cardiovascular and metabolic comorbidities. Importantly, individuals with well controlled blood pressure exhibited a lower prevalence of OH, providing rationale for the use of antihypertensive therapy in elderly persons with comorbid hypertension. PubMedCrossRef • Valbusa F, Labat C, Salvi P, et al. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30:53–60. This study examined the prevalance of OH in elderly persons living in nursing homes, and showed a positive association of this condition with arterial stiffness and cardiovascular and metabolic comorbidities. Importantly, individuals with well controlled blood pressure exhibited a lower prevalence of OH, providing rationale for the use of antihypertensive therapy in elderly persons with comorbid hypertension. PubMedCrossRef
68.
go back to reference Lipsitz LA, Gagnon M, Vyas M, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45:216–21.PubMedCrossRef Lipsitz LA, Gagnon M, Vyas M, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45:216–21.PubMedCrossRef
69.
go back to reference Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin. 2002;20:291–301. vii.PubMedCrossRef Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin. 2002;20:291–301. vii.PubMedCrossRef
70.
go back to reference Goldstein DS, Pechnik S, Holmes C, et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42:136–42.PubMedCrossRef Goldstein DS, Pechnik S, Holmes C, et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42:136–42.PubMedCrossRef
71.
go back to reference Arnold AC, Biaggioni I. Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens. 2012;21:481–5.PubMedCrossRef Arnold AC, Biaggioni I. Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens. 2012;21:481–5.PubMedCrossRef
72.
go back to reference Okamoto LE, Gamboa A, Shibao C, et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension. 2009;53:363–9.PubMedCrossRef Okamoto LE, Gamboa A, Shibao C, et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension. 2009;53:363–9.PubMedCrossRef
73.
go back to reference • Arnold AC, Okamoto LE, Gamboa A, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61:701–6. These studies provide evidence that angiotensin II levels are elevated in patients with primary autonomic failure and comorbid supine hypertension, despite often undetectable plasma renin activity. Moreover, single dose administration of the AT 1 receptor antagonist losartan, but not the ACE inhibitor captopril, lowered nocturnal blood pressure and and natriuresis without adversely affecting morning orthostatic tolerance in these patients. These findings provide new rational for the use of AT 1 blockers for the treatment of supine hypertension in autonomic failure. PubMedCrossRef • Arnold AC, Okamoto LE, Gamboa A, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61:701–6. These studies provide evidence that angiotensin II levels are elevated in patients with primary autonomic failure and comorbid supine hypertension, despite often undetectable plasma renin activity. Moreover, single dose administration of the AT 1 receptor antagonist losartan, but not the ACE inhibitor captopril, lowered nocturnal blood pressure and and natriuresis without adversely affecting morning orthostatic tolerance in these patients. These findings provide new rational for the use of AT 1 blockers for the treatment of supine hypertension in autonomic failure. PubMedCrossRef
74.
go back to reference Jordan J, Shannon JR, Pohar B, et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol. 1999;10:35–42.PubMed Jordan J, Shannon JR, Pohar B, et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol. 1999;10:35–42.PubMed
75.
go back to reference Gamboa A, Shibao C, Diedrich A, et al. Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension. 2008;51:1531–6.PubMedCrossRef Gamboa A, Shibao C, Diedrich A, et al. Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension. 2008;51:1531–6.PubMedCrossRef
76.
go back to reference Shibao C, Gamboa A, Abraham R, et al. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension. 2006;47:522–6.PubMedCrossRef Shibao C, Gamboa A, Abraham R, et al. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension. 2006;47:522–6.PubMedCrossRef
Metadata
Title
Current Concepts in Orthostatic Hypotension Management
Authors
Amy C. Arnold
Cyndya Shibao
Publication date
01-08-2013
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 4/2013
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-013-0362-3

Other articles of this Issue 4/2013

Current Hypertension Reports 4/2013 Go to the issue

Hypertension and the Heart (PW de Leeuw and AH Gradman, Section Editors)

The Role of Home Blood Pressure Telemonitoring in Managing Hypertensive Populations

Hypertension and the Heart (PW de Leeuw and AH Gradman, Section Editors)

Fructose-Containing Sugars, Blood Pressure, and Cardiometabolic Risk: A Critical Review

Secondary Hypertension: Adrenal and Nervous System Mechanisms (S Oparil, Section Editor)

Dysfunctional Brain-bone Marrow Communication: A Paradigm Shift in the Pathophysiology of Hypertension

Adrenal and Nervous System Mechanisms (S Oparil, Section Editor)

The Sympathetic Nervous System in Obesity Hypertension

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine